Prot#D6402C00001: A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Efficacy, Safety and Tolerability of Oral AZD9977 and Dapagliflozin Treatment in Patients with Heart Failure with Left Ventricular Ejection Frac

Project: Research project

Project Details

StatusFinished
Effective start/end date12/21/21 → 12/21/24

Funding

  • Parexel (Prot#D6402C00001 // Prot#D6402C00001)
  • AstraZeneca Pharmaceuticals LP (Prot#D6402C00001 // Prot#D6402C00001)